Could Gilead Make A Profit From Remdesivir?
Roche’s Tamiflu Was A Pandemic Blockbuster, But COVID-19 Is Different
All being well, Gilead could gain emergency approval for remdesivir by early May - but arriving at a 'reasonable' price and devising rapid access programs will be a major challenge.
